Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
170.69
+2.81 (1.67%)
At close: Aug 21, 2026, 4:00 PM EDT
170.65
-0.04 (-0.02%)
After-hours: Aug 21, 2026, 7:30 PM EDT

Guardant Health Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,183982.02739.02563.95449.54373.65
Revenue Growth
42.74%32.88%31.04%25.45%20.31%30.31%
Gross Profit
769.16633.01449.22336.9293.21250.74
Operating Income
-469.03-436.3-442.58-481.22-544.38-411
Net Income
-453.44-416.28-436.37-479.45-654.59-405.67
Earnings Per Share
-3.50-3.32-3.56-4.28-6.41-4.00
EPS Growth
------

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Oncology
798.41683.6542.83403.88
Biopharma and Data
222.66210.13177.58136.35
Screening
153.779.735.12-
Licensing and Other
8.348.5613.4923.72
Revenue (Total)
1,183982.02739.02563.95

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,0531,202839.981,1691,0111,631
Total Debt
1,6971,7101,3361,3541,3691,374
Net Cash (Debt)
-643.54-508.54-496.07-185.13-358.05257.05
Net Cash Growth
------78.34%
Net Cash Per Share
-4.97-4.06-4.04-1.65-3.502.54

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-185.19-184.76-239.86-324.98-309.46-209.02
Capital Expenditures
-55.54-48.31-35.09-20.49-77.46-75.04
Free Cash Flow
-240.72-233.07-274.94-345.46-386.92-284.05
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
65.01%64.46%60.79%59.74%65.22%67.11%
Operating Margin
-39.64%-44.43%-59.89%-85.33%-121.10%-110.00%
Pretax Margin
-38.41%-42.52%-58.87%-84.90%-145.36%-102.89%
Profit Margin
-38.33%-42.39%-59.05%-85.02%-145.61%-108.57%
FCF Margin
-20.35%-23.73%-37.20%-61.26%-86.07%-76.02%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
19.3613.405.115.826.2027.21